EP0714399A4 - HSV-2 UL26 GEN, ENVELOPE PROTEINS, IMMUNOASSAYS AND PROTEAS INHIBITORS - Google Patents
HSV-2 UL26 GEN, ENVELOPE PROTEINS, IMMUNOASSAYS AND PROTEAS INHIBITORSInfo
- Publication number
- EP0714399A4 EP0714399A4 EP94925924A EP94925924A EP0714399A4 EP 0714399 A4 EP0714399 A4 EP 0714399A4 EP 94925924 A EP94925924 A EP 94925924A EP 94925924 A EP94925924 A EP 94925924A EP 0714399 A4 EP0714399 A4 EP 0714399A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- hsv
- immunoassays
- gene
- protease inhibitors
- capsid proteins
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/503—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/705—Specific hybridization probes for herpetoviridae, e.g. herpes simplex, varicella zoster
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56994—Herpetoviridae, e.g. cytomegalovirus, Epstein-Barr virus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/01—DNA viruses
- G01N2333/03—Herpetoviridae, e.g. pseudorabies virus
- G01N2333/035—Herpes simplex virus I or II
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biophysics (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US110522 | 1987-10-20 | ||
US11052293A | 1993-08-20 | 1993-08-20 | |
US26453794A | 1994-06-23 | 1994-06-23 | |
US264537 | 1994-06-23 | ||
PCT/US1994/009303 WO1995006055A1 (en) | 1993-08-20 | 1994-08-19 | Hsv-2 ul26 gene, capsid proteins, immunoassays and protease inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0714399A1 EP0714399A1 (en) | 1996-06-05 |
EP0714399A4 true EP0714399A4 (en) | 1999-01-27 |
Family
ID=26808107
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP94925924A Withdrawn EP0714399A4 (en) | 1993-08-20 | 1994-08-19 | HSV-2 UL26 GEN, ENVELOPE PROTEINS, IMMUNOASSAYS AND PROTEAS INHIBITORS |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0714399A4 (es) |
JP (1) | JPH09503385A (es) |
CN (1) | CN1133594A (es) |
AU (1) | AU7568294A (es) |
CA (1) | CA2169748A1 (es) |
MX (1) | MXPA94006367A (es) |
WO (1) | WO1995006055A1 (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6083711A (en) * | 1996-05-15 | 2000-07-04 | Smithkline Beecham Corporation | Proteases compositions capable of binding to said site, and methods of use thereof |
WO1998000567A1 (en) * | 1996-07-01 | 1998-01-08 | Université de Montréal | Identification of a transforming fragment of herpes simplex type 2 and detection thereof in clinical specimens |
JP2001508649A (ja) * | 1996-11-04 | 2001-07-03 | スミスクライン・ビーチャム・コーポレイション | 2型単純ヘルペスウイルス由来の新規コーディング配列 |
US6143513A (en) * | 1999-06-23 | 2000-11-07 | Biacore Ab | Method and kit for detecting betalactam-containing compounds |
EP1523582B1 (en) | 2002-07-18 | 2008-11-12 | University of Washington | Rapid, efficient purification of hsv-specific t-lymphocytes and hsv antigens identified via same |
US8460674B2 (en) | 2009-02-07 | 2013-06-11 | University Of Washington | HSV-1 epitopes and methods for using same |
US9044447B2 (en) | 2009-04-03 | 2015-06-02 | University Of Washington | Antigenic peptide of HSV-2 and methods for using same |
WO2010135747A1 (en) | 2009-05-22 | 2010-11-25 | Genocea Biosciences Inc. | Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response |
CN101974613A (zh) * | 2010-10-15 | 2011-02-16 | 成都医学院 | 一种筛选抗hsv-1药物的试剂盒和方法 |
EP2643014A4 (en) | 2010-11-24 | 2015-11-11 | Genocea Biosciences Inc | HERPES SIMPLEX TYPE 2 VIRUS VACCINES: COMPOSITIONS AND METHODS FOR STIMULATING AN IMMUNE RESPONSE |
CA2885693C (en) | 2011-11-23 | 2020-07-28 | Genocea Biosciences, Inc. | Nucleic acid vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response |
CN107305212B (zh) * | 2016-04-25 | 2019-08-30 | 赵芳 | 一种有机磷类和氨基甲酸酯类农药的免疫学检测方法及试剂盒 |
CN107305213A (zh) * | 2016-04-25 | 2017-10-31 | 赵芳 | 一种检测有机磷类和氨基甲酸酯类农药的方法及试剂盒 |
WO2018064232A1 (en) | 2016-09-28 | 2018-04-05 | Genocea Biosciences, Inc. | Methods and compositions for treating herpes |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4430437A (en) * | 1980-08-27 | 1984-02-07 | The United States Of America As Represented By The Department Of Health And Human Services | Test methods employing monoclonal antibodies against Herpes simplex virus types 1 and 2 nucleocapsids proteins |
EP0514830A2 (en) * | 1991-05-24 | 1992-11-25 | Arch Development Corporation | Methods and compositions of a preparation and use of a herpes protease |
WO1993001291A1 (en) * | 1991-07-05 | 1993-01-21 | The Johns Hopkins University | Herpes virus proteinase and method of assaying |
EP0526652A1 (en) * | 1991-02-25 | 1993-02-10 | Iatron Laboratories, Inc. | Method of type-specific detection of herpes simplex virus |
WO1994029456A2 (en) * | 1993-06-08 | 1994-12-22 | Abbott Laboratories | Herpes simplex virus type-2 protease |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4709011A (en) * | 1982-02-18 | 1987-11-24 | University Patents, Inc. | Materials and methods for herpes simplex virus vaccination |
US4891315A (en) * | 1982-10-25 | 1990-01-02 | American Cyanamid Company | Production of herpes simplex viral porteins |
US4618578A (en) * | 1984-07-17 | 1986-10-21 | Chiron Corporation | Expression of glycoprotein D of herpes simplex virus |
US5324664A (en) * | 1988-08-08 | 1994-06-28 | The Upjohn Company | Herpes virus thymidien kinase-encoding DNA |
US5122449A (en) * | 1988-10-07 | 1992-06-16 | Eastman Kodak Company | Use of a protease in the extraction of chlamydial, gonococcal and herpes antigens |
-
1994
- 1994-08-19 AU AU75682/94A patent/AU7568294A/en not_active Abandoned
- 1994-08-19 JP JP7507654A patent/JPH09503385A/ja active Pending
- 1994-08-19 MX MXPA94006367A patent/MXPA94006367A/es unknown
- 1994-08-19 CA CA002169748A patent/CA2169748A1/en not_active Abandoned
- 1994-08-19 EP EP94925924A patent/EP0714399A4/en not_active Withdrawn
- 1994-08-19 WO PCT/US1994/009303 patent/WO1995006055A1/en not_active Application Discontinuation
- 1994-08-19 CN CN94193881A patent/CN1133594A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4430437A (en) * | 1980-08-27 | 1984-02-07 | The United States Of America As Represented By The Department Of Health And Human Services | Test methods employing monoclonal antibodies against Herpes simplex virus types 1 and 2 nucleocapsids proteins |
EP0526652A1 (en) * | 1991-02-25 | 1993-02-10 | Iatron Laboratories, Inc. | Method of type-specific detection of herpes simplex virus |
EP0514830A2 (en) * | 1991-05-24 | 1992-11-25 | Arch Development Corporation | Methods and compositions of a preparation and use of a herpes protease |
WO1993001291A1 (en) * | 1991-07-05 | 1993-01-21 | The Johns Hopkins University | Herpes virus proteinase and method of assaying |
WO1994029456A2 (en) * | 1993-06-08 | 1994-12-22 | Abbott Laboratories | Herpes simplex virus type-2 protease |
Non-Patent Citations (1)
Title |
---|
See also references of WO9506055A1 * |
Also Published As
Publication number | Publication date |
---|---|
EP0714399A1 (en) | 1996-06-05 |
CA2169748A1 (en) | 1995-03-02 |
MXPA94006367A (es) | 2004-09-09 |
CN1133594A (zh) | 1996-10-16 |
JPH09503385A (ja) | 1997-04-08 |
WO1995006055A1 (en) | 1995-03-02 |
AU7568294A (en) | 1995-03-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA99002203A (es) | Nuevos derivados de acetamida e inhibidores de proteasa. | |
IL112759A0 (en) | Novel cysteine protease inhibitors | |
EP0650844A3 (en) | Shuttle type printers and methods for its implementation. | |
DE69727586D1 (en) | Cysteine protease inhibitoren | |
ZA957263B (en) | Improved proteolytic enzyme cleaner. | |
HUP0000427A3 (en) | Benzamidoaldehydes and their use as cysteine protease inhibitors | |
ZA971810B (en) | Alkylphenylbisacylphosphine oxides and photoinitiator mixtures. | |
ZA977694B (en) | Heterocyclic metalloprotease inhibitors. | |
AU6121394A (en) | Methods and reagents for inhibiting furin endoprotease | |
ZA963619B (en) | Protease inhibitor peptides | |
AU5494294A (en) | Hop extract and use thereof | |
ZA9710646B (en) | Aminoguanidines and alkoxyguanidines as protease inhibitors | |
ZA978098B (en) | Designer proteases | |
EP0714399A4 (en) | HSV-2 UL26 GEN, ENVELOPE PROTEINS, IMMUNOASSAYS AND PROTEAS INHIBITORS | |
GB9405242D0 (en) | Developers for ps plates and replinishers therefor | |
AU2861695A (en) | Mn gene and protein | |
AU5340399A (en) | Proteases and associated proteins | |
AU7139598A (en) | Protease inhibitors | |
ZA949151B (en) | 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents. | |
EP0777746A4 (en) | TEST KIT FOR PROTEASE DETECTION | |
ZA97613B (en) | Aspartyl protease inhibitors | |
AU7518694A (en) | Retroviral protease inhibitors and combinations thereof | |
EP0880602A4 (en) | QUICK TEST FOR MICROBIAL PROTEASE | |
EP0614970A3 (de) | Inhibitoren der Hydroxyphenylpyruvat-Dioxygenase sowie Nachweisverfahren zur Identifizierung des Enzyms. | |
EP0685557A4 (en) | NEW METALLOPROTEASE AND DNA ENCODING THE SAME. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19960306 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: SI PAYMENT 960306 |
|
RAX | Requested extension states of the european patent have changed |
Free format text: SI PAYMENT 960306 |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 19981215 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
RHK1 | Main classification (correction) |
Ipc: C12N 15/57 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 19990302 |